Jakarta (Indonesia Window) – As many as eight million raw materials (bulk) of Sinovac’s COVID-19 vaccines arrived in Indonesia on Tuesday morning (May 25) via Soekarno Hatta Airport, Tangerang, Banten province.

With the arrival of the 13th phase of the vaccine in bulks, the total number of vaccines received by Indonesia so far is 83.9 million doses.

"The vaccines that have been received consist of 3 million doses of ready-to-use Sinovac vaccines, 6.4 million doses of AstraZeneca, and 1 million doses of Sinopharm. With the arrival of the 13th phase of Sinovac bulk vaccine today, as many as 8 million doses, a total of 83.9 million doses of vaccines have been received by Indonesia," said Coordinating Minister for Economic Affairs Airlangga Hartarto in a press statement welcoming the arrival of the vaccine.

He added that the arrival of raw material vaccine is part of the government's efforts to continue to maintain the supply of the COVID-19 vaccine in order to achieve the target of herd immunity.

"The government always maintains the availability of vaccine stocks so that vaccination is in accordance with the targets that have been set," Airlangga said.

To achieve herd immunity, the Indonesian government is targeting vaccinations to approximately 181.5 people or 70 percent of the country's population.

Airlangga emphasized that the government always ensures the safety, quality, and efficacy aspects of each vaccine used by the country.

"There is no need to hesitate in receiving the vaccine. Vaccines which are provided in Indonesia have been through evaluation processes by National Agency of Drug and Food Control (BPOM) under the considerations from experts, from ITAGI (Indonesian Technical Advisory Group on Immunization), and WHO," he said.

Reporting by Indonesia Window